Geron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
CEOHarout Semerjian
CEOHarout Semerjian
Employees229
Employees229
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded1990
Founded1990
Employees229
Employees229
GERN Key Statistics
Market cap768.81M
Market cap768.81M
Price-Earnings ratio-9.28
Price-Earnings ratio-9.28
Dividend yield—
Dividend yield—
Average volume8.64M
Average volume8.64M
High today$1.25
High today$1.25
Low today$1.19
Low today$1.19
Open price$1.22
Open price$1.22
Volume5.25M
Volume5.25M
52 Week high$4.50
52 Week high$4.50
52 Week low$1.09
52 Week low$1.09
GERN News
TipRanks 4d
Geron Announces Executive Leadership TransitionsElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 4d
Geron COO Andrew Grethlein, CCO Jim Ziegler to departGeron (GERN) announced several executive transitions and appointments designed to align the company’s leadership structure with its strategic priorities. Andrew...
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
12.5%
Sell
12.5%
People also own
Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.